Listed pharmaceutical firms’ operating profit nosedives 46% in 1Q

Korea’s 54 pharmaceutical firms saw their earnings plunge 45.9 percent during the first quarter, even before a government-mandated price cut came into effect, data showed on Monday.

According to the data compiled by Yakup.com, a pharmaceutical information provider on large businesses, the combined operating profit of 34 KOSPI-listed companies reached 113.2 billion won in the first three mont...